Top

Published in:

01-03-2016 | Essay

Financing prevention: opportunities for economic analysis across the translational research cycle

Authors: D. Max Crowley, PhD, Damon Jones, PhD

Published in: Translational Behavioral Medicine | Issue 1/2016

Abstract

Prevention advocates often make the case that preventive intervention not only improves public health and welfare but also can save public resources. Increasingly, evidence-based policy efforts considering prevention are focusing on how programs can save taxpayer resources from reduced burden on health, criminal justice, and social service systems. Evidence of prevention’s return has begun to draw substantial investments from the public and private sector. Yet, translating prevention effectiveness into economic impact requires specific economic analyses to be employed across the stages of translational research. This work discusses the role of economic analysis in prevention science and presents key translational research opportunities to meet growing demand for estimates of prevention’s economic and fiscal impact.

Baron J, Haskins R. The Obama Administration’s evidence-based social policy initiatives: an overview. 2011. Retrieved from http://www.brookings.edu/opinions/2011/1102_budget_deficit_haskins.aspx

Catalano RF, Fagan AA, Gavin LE, et al. Worldwide application of prevention science in adolescent health. Lancet. 2012; 379(9826): 1653-1664. doi:10.1016/S0140-6736(12)60238-4.CrossRefPubMedPubMedCentral

O’Connell ME, Boat TF, Warner KE. Preventing mental, emotional, and behavioral disorders among young people: progress and possibilities. Washington: National Academies Press; 2009.

Thompson DK, Clark MJ, Howland LC, et al. The patient protection and affordable care act of 2010 (PL 111–148): an analysis of maternal-child health home visitation. Policy, Politics, Nursing Pract. 2011; 12(3): 175-185. doi:10.1177/1527154411424616.CrossRef

Belfield C, Nores M, Barnett S, et al. The high/scope perry preschool program: cost-benefit analysis using data from the age-40 follow up. J Hum Resour. 2006; 41(1): 162-190.CrossRef

Heckman J, Moon SH, Pinto R, et al. The rate of return to the HighScope perry preschool program. J Public Econ. 2010; 94: 114-128. doi:10.1016/j.jpubeco.2009.11.001.CrossRefPubMedPubMedCentral

Reynolds AJ, Temple JA, Robertson DL, et al. Age 21 cost-benefit analysis of the title I Chicago child–parent centers. Educ Eval Policy Analysis. 2002; 24(4): 267-303. doi:10.3102/01623737024004267.CrossRef

Kuklinski MR, Briney JS, Hawkins JD, et al. Cost-benefit analysis of communities that care outcomes at eighth grade. Prev Sci. 2012. doi:10.1007/s11121-011-0259-9.PubMedPubMedCentral

Beatty AS. Strengthening benefit-cost analysis for early childhood interventions workshop summary. Washington: National Academies Press; 2009.

10.

Crowley DM, Hill LG, Kuklinski MR, Jones D. Research priorities for economic analyses of prevention: current issues & future directions. Prev Sci, 2013.

11.

Karoly LA. Toward standardization of benefit-cost analyses of early childhood interventions. SSRN Electron J. 2011. doi:10.2139/ssrn.1753326.

12.

Lee S, Aos S, Drake EK, Pennucci A, Miller GE, Anderson L. Return on investment: evidence-based options to improve statewide outcomes April 2012 update. Olympia, WA: Washington State Institute for Public Policy, 2012. Retrieved from http://www.wsipp.wa.gov/pub.asp?docid=12-04-1201

13.

Brown CH, Kellam SG, Kaupert S, et al. Partnerships for the design, conduct, and analysis of effectiveness, and implementation research: experiences of the prevention science and methodology group. Adm Policy Ment Health Ment Health Serv Res. 2011. doi:10.1007/s10488-011-0387-3.

14.

Crowley DM, Jones DE, Greenberg MT, et al. Resource consumption of a diffusion model for prevention programs: the PROSPER delivery system. J Adolesc Health. 2012; 50(3): 256-263. doi:10.1016/j.jadohealth.2011.07.001.CrossRefPubMedPubMedCentral

15.

Aos S, Lieb R, Mayfield J, Miller M, Pennucci A. Benefits and costs of prevention and early intervention programs for youth, 2004: Retrieved from http://www.wsipp.wa.gov/pub.asp?docid=04-07-3901

16.

Asemati H, Belinsky M, Gillette R, Liebman J, Sellman A, Wyse A. Social Impact bonds: lessons learned so far. Santa Monica, CA: Federal Reserve Bank of San Francisco; 2013. Retrieved from http://www.frbsf.org/community-development/files/social-impact-bonds-lessons-learned.pdf

17.

The Pew Charitable Trusts. Results first, 2012. Retrieved from http://www.pewstates.org/projects/results-first-328069.

18.

Chalkidou K, Lord J, Fischer A, et al. Evidence-based decision making: when should we wait for more information? Health Aff. 2008; 27(6): 1642-1653. doi:10.1377/hlthaff.27.6.1642.CrossRef

19.

Drake EK, Aos S, Miller MG. Evidence-based public policy options to reduce crime and criminal justice costs: implications in Washington state. Victims Offenders. 2009; 4(2): 170-196. doi:10.1080/15564880802612615.CrossRef

20.

Costa K. Washington state shows what works data-driven analysis of public programs reaps many benefits. 2012. Retrieved from http://www.americanprogress.org/issues/2012/02/washington_what_works.html

21.

Dueffert N. Better results, lower costs washington state’s cutting-edge policy analysis Mod. Pew Center fo the States. 2012. Retrieved from http://www.pewstates.org/uploadedFiles/PCS_Assets/2012/ResultsFirst_Washington_casestudy.pdf

22.

Results First. Achieving success with the Pew-MacArthur results first initiative a state progress report 2011–13. Washington D.C.: Pew Center fo the States, 2013. Retrieved from http://www.pewtrusts.org/~/media/legacy/uploadedfiles/pcs_assets/2014/RFStateSuccessesbriefARTFINALv5pdf.pdf

23.

Dodge KA, Mandel AD. Building evidence for evidence-based policy making: delinquency prevention. Criminol Public Policy. 2012; 11(3): 525-534. doi:10.1111/j.1745-9133.2012.00828.x.CrossRefPubMedPubMedCentral

24.

Liebman J. Building on recent advances in evidence-based policymaking. Washington: Brookings Institution; 2013.

25.

Greenblatt J. The promise of pay for success. Comm Dev Invest Rev, 2013: 9(1).

26.

Liebman J, Sellman A. Social impact bonds a guide for state and local governments. Cambridge: Social Impact Bond Technical Assistance Lab; 2013.

27.

Callanan L, Law J. Pay for success: opportunities and risks for nonprofits. Comm Develop Invest Rev, 2013: 9(1).

28.

Third Sector Capital Partners. Case study: preparing for a pay for success opportunity. Boston, MA: Third Sector Capital, 2013. Retrieved from http://www.thirdsectorcap.org/wp-content/uploads/2013/04/Third-Sector_Roca_Preparing-for-Pay-for-Success-in-MA.pdf

29.

Valadmanis R. Massachusetts uses largest “social impact bond” to tackle crime. Reuters. New York, NY, 2013. Retrieved from http://www.reuters.com/article/2014/01/29/us-usa-massachusetts-socialbond-idUSBREA0S1QI20140129

30.

Crowley M. The role of social impact bonds in pediatric health care. Pediatrics. 2014; 134(2): 331-333. doi:10.1542/peds.2013-4056.CrossRef

31.

AHRQ. U.S. Preventive Services Task Force (USPSTF): an introduction. Rockville, MD: Agency for Healthcare Research and Quality, 2012. Retrieved from http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/uspstf/index.html

32.

AHRQ. U.S. Preventive services task force procedure manual. (No. AHRQ Publication No. 08-05118-EF). Washington D.C.: Agency for Healthcare Research and Quality, 2011. Retrieved from http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm

33.

USPSTF. USPSTF Grade definitions after july 2012. Washington D.C, 2014. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions#grade-definitions-after-july-2012

34.

USPSTF. Update on methods: estimating certainty and magnitude of net benefit. U.S. Preventive Services Task Force, 2014. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Name/update-on-methods-estimating-certainty-and-magnitude-of-net-benefit#copyright-and-source-information

35.

Foster EM, Dodge KA, Jones D. Issues in the economic evaluation of prevention programs. Appl Dev Sci. 2003; 7: 76-86. doi:10.1207/S1532480XADS0702_4.CrossRefPubMedPubMedCentral

36.

Baron J. Demonstrating how low-cost randomized controlled trials can drive effective social spending: Washington D.C.: Coalition for Evidnece-Based Policy, 2013. Retrieved from http://coalition4evidence.org/wp-content/uploads/2013/12/Low-cost-RCT-competition-December-2013.pdf

37.

Head BW. Reconsidering evidence-based policy: key issues and challenges. Policy Soc. 2010; 29(2): 77-94. doi:10.1016/j.polsoc.2010.03.001.CrossRef

38.

Karoly LA. Investing in our children: what we know and don’t know about the costs and benefits of early childhood interventions. Santa Monica: Rand; 1998.

39.

Kilburn K, Karoly LA. The economics of early childhood policy what the dismal science has to say about investing in children. 2008. Retrieved from http://www.rand.org/pubs/occasional_papers/OP227.html

40.

Boardman AE, Greenberg DH, Vining AR, et al. Plug-in shadow price estimates for policy analysis. Ann Reg Sci. 1997; 31: 299-324. doi:10.1007/s001680050051.CrossRef

41.

Heckman J. Shadow prices, market wages, and labor supply. Econometrica, 1974: 679–694.

42.

Vining A, Weimer DL. An assessment of important issues concerning the application of benefit-cost analysis to social policy. J Benefit-Cost Analysis, 2010: 1(1). doi:10.2202/2152-2812.1013

43.

Jones DE, Greenberg M, Crowley M. Early social-emotional functioning and public health: the relationship between kindergarten social competence and future wellness. Am J Public Health, 2015: e1–e8. doi:10.2105/AJPH.2015.302630

44.

Levin H, Belfield C, Muennig PA, Rouse C. The costs and benefits of an excellent education for all of America’s children. New York, NY: Columbia University, 2006. Retrieved from http://www3.nd.edu/~jwarlick/documents/Levin_Belfield_Muennig_Rouse.pdf

45.

Bates ME, Labouvie EW. Adolescent risk factors and the prediction of persistent alcohol and drug use into adulthood. Alcohol Clin Exp Res. 1997; 21(5): 944-950. doi:10.1111/j.1530-0277.1997.tb03863.x.CrossRefPubMed

46.

Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull. 1992; 112(1): 64-105. doi:10.1037/0033-2909.112.1.64.CrossRefPubMed

47.

Duckworth AL. The significance of self-control. Proc Natl Acad Sci. 2011; 108(7): 2639-2640. doi:10.1073/pnas.1019725108.CrossRefPubMedPubMedCentral

48.

Heckman J. Skill formation and the economics of investing in disadvantaged children. Science. 2006; 312(5782): 1900-1902. doi:10.1126/science.1128898.CrossRefPubMed

49.

Moffitt TE, Arseneault L, Belsky D, et al. A gradient of childhood self-control predicts health, wealth, and public safety. Proc Natl Acad Sci. 2011; 108(7): 2693-2698. doi:10.1073/pnas.1010076108.CrossRefPubMedPubMedCentral

50.

Conduct Problems Prevention Research Group, Jones DE, Foster EM. Service use patterns for adolescents with ADHD and comorbid conduct disorder. J Behav Health Services Res. 2008; 36(4): 436-449. doi:10.1007/s11414-008-9133-3.

51.

Karoly LA. Valuing benefits in benefit-cost studies of social programs. Technical Report. RAND. 2008. Retrieved from http://www.rand.org/content/dam/rand/pubs/technical_reports/2008/RAND_TR643.pdf

52.

Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health. 1996; 86(12): 1709-1712. doi:10.2105/AJPH.86.12.1709.CrossRefPubMedPubMedCentral

53.

Cicchetti D, Rogosch FA. Equifinality and multifinality in developmental psychopathology. Dev Psychopathol. 2009; 8(04): 597. doi:10.1017/S0954579400007318.CrossRef

54.

Collins LM, Murphy SA, Strecher V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART). Am J Prev Med. 2007; 32(5): S112-S118. doi:10.1016/j.amepre.2007.01.022.CrossRefPubMedPubMedCentral

55.

Huffman WE. Allocative efficiency: the role of human capital. Q J Econ. 1977; 91(1): 59. doi:10.2307/1883138.CrossRef

56.

Collins LM, Murphy SA, Nair VN, et al. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005; 30: 65-73. doi:10.1207/s15324796abm3001_8.CrossRefPubMed

57.

Crowley DM. Building efficient crime prevention strategies considering the economics of investing in human development. Criminol Public Policy. 2013; 12(2): 353.CrossRefPubMedPubMedCentral

58.

Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, et al. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health. 2005; 8(3): 178-190. doi:10.1111/j.1524-4733.2005.04008.x.CrossRefPubMed

59.

Max Crowley D, Jones DE, Coffman DL, et al. Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial. Prev Med. 2014. doi:10.1016/j.ypmed.2014.01.029.PubMedPubMedCentral

60.

Foster EM, Prinz RJ, Sanders MR, et al. The costs of a public health infrastructure for delivering parenting and family support. Child Youth Serv Rev. 2008; 30(5): 493-501. doi:10.1016/j.childyouth.2007.11.002.CrossRef

61.

Haddix AC, Teutsch SM, Corso PS. Prevention effectiveness: a guide to decision analysis and economic evaluation. Oxford: Oxford University Press; 2003.

62.

Levin & McEwan. Cost-effectiveness analysis: methods and applications. 2000. Retrieved March 15, 2011, from http://books.google.com/books?hl=en&lr=&id=HniLG23vYDwC&oi=fnd&pg=PR15&dq=%22comparison+group*%22+in+cost-effectiveness+analysis&ots=cIosgGlSjI&sig=−H4khQJnQCjqPlzUAgAR-Mwsc5E#v=onepage&q=comparison%20group&f=false

63.

Cost-effectiveness in health and medicine. New York: Oxford University Press. 1996.

64.

Hoffmann C, Stoykova BA, Nixon J, et al. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health. 2002; 5: 71-78. doi:10.1046/j.1524-4733.2002.52109.x.CrossRefPubMed

65.

Foster EM, Porter MM, Ayers TS, et al. Estimating the costs of preventive interventions. Eval Rev. 2007; 31(3): 261-286. doi:10.1177/0193841X07299247.CrossRefPubMed

66.

Flay BR, Biglan A, Boruch RF, et al. Standards of evidence: criteria for efficacy, effectiveness and dissemination. Prev Sci. 2005; 6: 151-175. doi:10.1007/s11121-005-5553-y.CrossRefPubMed

67.

Drummond MF. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2005.

68.

Aos S, Lee S, Drake EK, Pennucci A, Klima T, Millier M, Burley M. Return on investment: evidence-based options to improve statewide outcomes. 2011 Retrieved from http://www.wsipp.wa.gov/pub.asp?docid=11-07-1201

69.

Coker A, Reeder C, Fadden M, et al. Physical partner violence and Medicaid utilization and expenditures. Public Health Rep. 2004; 119(6): 557-567. doi:10.1016/j.phr.2004.09.005.CrossRefPubMedPubMedCentral

70.

McLellan AT. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA: J Am Med Assoc. 2000; 284(13): 1689-1695. doi:10.1001/jama.284.13.1689.CrossRef

71.

Miller TR, Cohen MA, Rossman SB. Victim costs of violent crime and resulting injuries. Health Aff. 1993; 12(4): 186-197. doi:10.1377/hlthaff.12.4.186.CrossRef

72.

Cohen MA, Rust RT, Steen S, et al. Willingness-to-pay for crime control programs*. Criminology. 2004; 42(1): 89-110. doi:10.1111/j.1745-9125.2004.tb00514.x.CrossRef

73.

Miller T. Nurse-family partnership home visitation: costs, outcomes, and return on investment. Bethesda, MD: HBSA INC. 2013. Retrieved from http://www.pewstates.org/uploadedFiles/PCS_Assets/2013/Costs_and_ROI_report.pdf

74.

Cohen MA. The costs of crime and justice. New York: Routledge; 2005.CrossRef

75.

Cohen MA. Pain, suffering, and jury awards: a study of the cost of crime to victims. Law Soc Rev. 1988; 22(3): 537. doi:10.2307/3053629.CrossRef

76.

Birch S. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? J Health Econ. 1992; 11(3): 279-296. doi:10.1016/0167-6296(92)90004-K.CrossRefPubMed

77.

Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health. Annu Rev Public Health. 2002; 23(1): 115-134. doi:10.1146/annurev.publhealth.23.100901.140513.CrossRefPubMed

78.

Finn J, Hayward J. Bringing success to scale: pay for success and housing homeless individuals in Massachusetts. Community Development Investment Review, 2013: 9(1).

79.

Dueffert N. States’ use of cost-benefit analysis improving results for taxpayers. Pew-Macarthur Results First Initiative. 2013. Retrieved from http://www.pewstates.org/uploadedFiles/PCS_Assets/2013/Pew_Results_First_50state_report.pdf

80.

Fagan AA, Hanson K, Hawkins JD, et al. Bridging science to practice: achieving prevention program implementation fidelity in the community youth development study. Am J Community Psychol. 2008; 41(3–4): 235-249. doi:10.1007/s10464-008-9176-x.CrossRefPubMed

81.

Gruen R, Elliott J, Nolan M, et al. Sustainability science: an integrated approach for health-programme planning. Lancet. 2008; 372(9649): 1579-1589. doi:10.1016/S0140-6736(08)61659-1.CrossRefPubMed

82.

Heinrichs N, Bertram H, Kuschel A, et al. Parent recruitment and retention in a universal prevention program for child behavior and emotional problems: barriers to research and program participation. Prev Sci. 2005; 6(4): 275-286. doi:10.1007/s11121-005-0006-1.CrossRefPubMed

83.

Dusenbury L. A review of research on fidelity of implementation: implications for drug abuse prevention in school settings. Health Educ Res. 2003; 18(2): 237-256. doi:10.1093/her/18.2.237.CrossRefPubMed

84.

Golden M. Developing a social impact bond: lessons from a provider. New York, NY: The Childrens’ Aid Society. 2013. Retrieved from http://www.childrensaidsociety.org/files/upload-docs/CAS_FINAL_Report.pdf

85.

Perkins DF, Feinberg ME, Greenberg MT, et al. Team factors that predict to sustainability indicators for community-based prevention teams. Eval Program Planning. 2011; 34(3): 283-291. doi:10.1016/j.evalprogplan.2010.10.003.CrossRef

86.

Goodman RM, Speers MA, Mcleroy K, et al. Identifying and defining the dimensions of community capacity to provide a basis for measurement. Health Educ Behav. 1998; 25(3): 258-278. doi:10.1177/109019819802500303.CrossRefPubMed

87.

Johnson K. Building capacity and sustainable prevention innovations: a sustainability planning model. Eval Program Planning. 2004; 27(2): 135-149. doi:10.1016/j.evalprogplan.2004.01.002.CrossRef

88.

Office of National Drug Control Policy. The economic costs of drug abuse in the United States (No. Publication No. 207303). Washington D.C.: Exectuive Office of the President. 2004. Retrieved from https://www.ncjrs.gov/ondcppubs/publications/pdf/economic_costs.pdf

89.

White D, Holand A. Benefit-cost analysis: what are states doing? Washington: Pew Center fo the States; 2013.

90.

Canavan T, Elovainio R. Performance based financing : an international review of the literature. Royal Tropical Institute, 2008.

91.

Dugger R. Success begins with a feasibility study. Community Development Investment Review, 2013: 9(1).

92.

Marsh K, Bertranou E, Samanata K. Cost-benefit analysis and social impact bond feasibility analysis for the Birmingham Be Active scheme. Matric Evidence, 2011. Retrieved from http://www.socialfinance.org.uk/sites/default/files/matrix_be_active_final_report.pdf

93.

Costa K, Shah S. Government’s role in pay for success. Community Development Investment Review, 2013: 9(1).

Title: Financing prevention: opportunities for economic analysis across the translational research cycle
Authors: D. Max Crowley, PhD
Damon Jones, PhD
Publication date: 01-03-2016
Publisher: Springer US
Published in: Translational Behavioral Medicine / Issue 1/2016
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI: https://doi.org/10.1007/s13142-015-0354-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Financing prevention: opportunities for economic analysis across the translational research cycle

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Illustrating idiographic methods for translation research: moderation effects, natural clinical experiments, and complex treatment-by-subgroup interactions

The full translational spectrum of prevention science

Transforming community prevention systems for sustained impact: embedding active implementation and scaling functions

Application of environmental sensitivity theories in personalized prevention for youth substance abuse: a transdisciplinary translational perspective

Risk and resistance perspectives in translation-oriented etiology research

Factors associated with the implementation of the Familias Unidas intervention in a type 3 translational trial